October 2025

2
The securities industry requires extensive real-time data exchange and continuous information communication, which place high demands on data center cooling solutions. Recently, Evapco’s aftermarket team successfully implemented a comprehensive cooling system upgrade for a leading securities firm in Shanghai, enhancing system reliability and securing uninterrupted data communication. Key features of the comprehensive cooling solution include:
d
The Legionnaires' Disease Origins, Myths and Prevention Video has been released! It explains the pathogenesis and high-risk groups of Legionnaires disease, clarifies the myth of Legionella transmission via HVAC cooling tower plumes, and covers infection points and prevention methods. You can watch the video via https://www.evapcoasia.com/video-library/new/legionnaires-disease-origins-myths-and-prevention
B
Evapco is pleased to announce the official inauguration of its comprehensively upgraded Asia-Pacific Operations Center. We were deeply honored to have Mr. Bill Bartley, Chairman of the Evapco Board of Directors & CEO • Executive Director, preside over the ribbon-cutting ceremony for this significant milestone in the company's strategic development across the Asia-Pacific region. This transformation extends far beyond a physical renovation—it stands as a powerful testament to Evapco's steadfast commitment to deepening its presence in the Asia-Pacific market. The newly enhanced center, with its
B
On October 9 2025, coinciding with the second day of the Data Centre World (DCW) exhibition in Singapore, EVAPCO Asia-Pacific meticulously orchestrated an industry gathering at the L3 Saraca Ballroom, Marina Bay Sands. This event seamlessly blended in-depth knowledge sharing with relaxed networking, inviting distinguished guests from various sectors to discuss technology and explore collaboration, culminating in a highly successful conclusion. The success of this event is a testament to the unwavering support and active participation of every guest. Although the event has concluded, EVAPCO's